Mark Zuckerberg-Backed AI Startup Takes Over Parkinson’s Treatment From the Maker of Ozempic
AI Summary
Cellular Intelligence just acquired the rights to an experimental Parkinson’s cell therapy from Novo Nordisk.
Discussion
Sign in to join the discussion.
Loading comments…